| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 March 1998 | Volume 128 Issue 6 | Pages 478-487
Purpose: To determine whether the seeming relation between low or lowered cholesterol levels and violence is consistent with causality according to Hill's criteria and whether construct validity is supported by convergence of findings across different types of studies.
Data Sources: Search of the MEDLINE database for English-language articles published between 1965 and 1995 was supplemented by searches of the PsycINFO and Current Contents databases and bibliographies of relevant articles.
Study Selection: Peer-reviewed observational and experimental articles and meta-analyses that presented original research; related cholesterol levels to behaviorally defined violence; and if experimental, had single-factor (lipid-only) intervention.
Data Extraction: Studies were grouped according to type. Data on the relation of violence to cholesterol levels from each study were recorded.
Data Synthesis: Observational studies (including cohort, casecontrol, and cross-sectional studies) consistently showed increased violent death and violent behaviors in persons with low cholesterol levels. Some meta-analyses of randomized trials found excess violent deaths in men without heart disease who were randomly assigned to receive cholesterol-lowering therapy. Experimental studies showed increased violent behaviors in monkeys assigned to low-cholesterol diets. Human and animal research indicates that low or lowered cholesterol levels may reduce central serotonin activity, which in turn is causally linked to violent behaviors. Many trials support a significant relation between low or lowered cholesterol levels and violence (P < 0.001).
Conclusions: A significant association between low or lowered cholesterol levels and violence is found across many types of studies. Data on this association conform to Hill's criteria for a causal association. Concerns about increased risk for violent outcomes should Figure in riskbenefit analyses for cholesterol screening and treatment.
Author and Article Information
From the University of California, Los Angeles, Los Angeles, California. For the current author address, see end of text.
PERSPECTIVE
Cholesterol and Violence: Is There a Connection?
![]()
Disclaimer: The views expressed here are solely those of the author and do not necessarily reflect those of the funding agencies.
Acknowledgments: The author thanks Drs. Robert Brook, Michael Criqui, Naihua Duan, Arlene Fink, Hal Morgenstern, Sally Morton, Terrence Sejnowski, and Paul Shekelle for methodologic advice and assistance and Shannon Bush for help with references.
Grant Support: By grants from the Robert Wood Johnson Clinical Scholars Program and the Harry Frank Guggenheim Foundation.
Requests for Reprints: Beatrice A. Golomb, MD, PhD, Department of Medicine, University of California San Diego/San Diego Veterans Affairs Medical Center, 3350 La Jolla Village Drive 111N-1, La Jolla, CA 92161.
This article has been cited by other articles:
![]() |
D. Cakiroglu, Y. Meral, A. A. Sancak, and G. Cifti Relationship between the serum concentrations of serotonin and lipids and aggression in dogs Vet Rec., July 14, 2007; 161(2): 59 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. E. Magnusson, F. Rasmussen, D. A. Lawlor, P. Tynelius, and D. Gunnell Association of Body Mass Index with Suicide Mortality: A Prospective Cohort Study of More than One Million Men Am. J. Epidemiol., January 1, 2006; 163(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, M. F. Muldoon, R. E. McKeown, and S. P. Cuffe Association of Serum Cholesterol and History of School Suspension among School-age Children and Adolescents in the United States Am. J. Epidemiol., April 1, 2005; 161(7): 691 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lalovic, L. Merkens, L. Russell, G. Arsenault-Lapierre, M. J.M. Nowaczyk, F. D. Porter, R. D. Steiner, and G. Turecki Cholesterol Metabolism and Suicidality in Smith-Lemli-Opitz Syndrome Carriers Am J Psychiatry, November 1, 2004; 161(11): 2123 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Fox, B. J. Hoogwerf, S. Czajkowski, R. Lindquist, G. Dupuis, J. A. Herd, L. Campeau, A. Hickey, F. B. Barton, and M. L. Terrin Quality of Life After Coronary Artery Bypass Graft: Results From the POST CABG Trial Chest, August 1, 2004; 126(2): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.A. Golomb, T. Kane, and J.E. Dimsdale Severe irritability associated with statin cholesterol-lowering drugs QJM, April 1, 2004; 97(4): 229 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Golomb, M. H. Criqui, H. White, and J. E. Dimsdale Conceptual Foundations of the UCSD Statin Study: A Randomized Controlled Trial Assessing the Impact of Statins on Cognition, Behavior, and Biochemistry Arch Intern Med, January 26, 2004; 164(2): 153 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Juurlink Does the treatment of dyslipidemia affect the risk of depression or suicidal behaviour? Can. Med. Assoc. J., January 20, 2004; 170(2): 192 - 192. [Full Text] |
||||
![]() |
T. Ormiston, O. M. Wolkowitz, V. I. Reus, and F. Manfredi Behavioral Implications of Lowering Cholesterol Levels: A Double-Blind Pilot Study Psychosomatics, October 1, 2003; 44(5): 412 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mysterud and D. V. Poleszynski Expanding Evolutionary Psychology: toward a Better Understanding of Violence and Aggression Social Science Information, March 1, 2003; 42(1): 5 - 50. [Abstract] [PDF] |
||||
![]() |
J. J. Mann A Current Perspective of Suicide and Attempted Suicide Ann Intern Med, February 19, 2002; 136(4): 302 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Muldoon, S. B Manuck, A. B Mendelsohn, J. R Kaplan, and S. H Belle Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials BMJ, January 6, 2001; 322(7277): 11 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Stewart, K. J. Sharples, F. M. North, D. B. Menkes, J. Baker, J. Simes, and for the LIPID Study Investigators Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin Arch Intern Med, November 13, 2000; 160(20): 3144 - 3152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tanskanen, E. Vartiainen, J. Tuomilehto, H. Viinamäki, J. Lehtonen, and P. Puska High Serum Cholesterol and Risk of Suicide Am J Psychiatry, April 1, 2000; 157(4): 648 - 650. [Abstract] [Full Text] |
||||
![]() |
Other Articles Noted Evid. Based Nurs., October 1, 1998; 1(4): 100 - 104. [Full Text] |
||||
![]() |
J. M. Dietschy and S. D. Turley Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J. Lipid Res., August 1, 2004; 45(8): 1375 - 1397. [Abstract] [Full Text] [PDF] |
||||